Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -0.422% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
[a] COc1ccc(N2CC(C(=O)OCC(=O)Nc3ccccc3C)CC2=O)cc1
[b] Cn1c(NC(=O)CCc2ccccc2)cc(=O)n(C)c1=O
[c] COc1cc(Nc2nc3ccc(Cl)cc3n3cnnc23)cc(OC)c1OC
Answer: b. Cn1c(NC(=O)CCc2ccccc2)cc(=O)n(C)c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1c(NC(=O)CCc2ccccc2)cc(=O)n(C)c1=O
Cn1c(NC(=O)CCc2ccccc2)cc(=O)n(C)c1=O
N-(1,3-dimethyl-2,6-dioxopyrimidin-4-yl)-3-phenylpropanamide